The Trump administration announced Wednesday that the federal government would sharply curtail federal spending on medical research that uses tissue from aborted fetuses, mainly by ending fetal-tissue research within the National Institutes of Health

Quick Read

A three-judge panel of the Seventh U.S. Circuit Court of Appeals this month overturned a lower court decision that an Indiana law criminalizing much fetal tissue research is unconstitutionally vague

Quick Read

The U.S. government’s leading medical research agency is quietly extending and reviving research that relies on human fetal tissue, even as President Donald Trump’s administration ponders the future of the controversial work in a far-reaching review

Quick Read

The National Institutes of Health freeze on fetal tissue procurement is threatening to hamper work at an agency lab conducting cancer research, the latest sign that a Trump administration decision could slow the efforts of some scientists who depend on the samples

Quick Read

The announcement is largely preliminary. The formal funding opportunity announcements will be published at some date in the future, the agency said, and scientists cannot yet submit proposals to be funded

Quick Read

The US Department of Health and Human Services is vigorously contesting a report, published by The Washington Post, that it has decided to cancel a $2-million-a-year contract that funds work using human fetal tissue to develop mice with humanlike immune systems for testing drugs against HIV

Quick Read

The U.S. Department of Health and Human Services (HHS) in Washington, D.C., which funds much of the nation’s biomedical research, has launched a “comprehensive review” of human fetal tissue research, to ensure that it’s complying with laws and regulations

Quick Read

Will Trump intervene? How will a Donald J. Trump administration handle these ethically delicate materials?

Quick Read